American Century Companies’s Tourmaline Bio TRML Stock Holding History

American Century Companies's TRML Position: Q4 2025 in Review

American Century Companies sold out of Tourmaline Bio (TRML) in Q4 2025, closing a stake of 47,788 shares — an estimated $2.29M sold.

American Century Companies first reported a position in TRML in Q4 2023 and held it in 6 quarters. The position peaked at $2.29M in Q3 2025. 0 funds tracked by Wall St. Rank hold TRML as of Q4 2025.

• American Century Companies reported no remaining Tourmaline Bio position as of Q4 2025 after selling out during the quarter.
• American Century Companies sold 47,788 Tourmaline Bio shares in Q4 2025, an estimated $2.29M.
• American Century Companies first reported a position in Tourmaline Bio in Q4 2023 and held it in 6 quarters.
• American Century Companies's Tourmaline Bio position peaked at $2.29M in Q3 2025.
• 0 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2025.

Based on American Century Companies's 13F filing for Q4 2025, filed 13 Feb 2026.